Thammasat University
Khlong Luang, Changwat Pathum Thani, 12120, Thailand
NCT Number: NCT06312527
The goal of this RCT is comparing efficacy of silicone dressing in scar preventing after simultaneous bilateral total knee arthroplasty.
The main question[s] it aims to answer are:
* Does silicone dressing can prevent scar formation after total knee arthroplasty? * Does silicone dressing have similar functional outcomes and complications after total knee arthroplasty? Participants will apply silicone dressing after wound healed and apply for 10 weeks. Researchers will compare to the other side that is no intervention.
This study is active but is not currently recruiting participants.
50 year–80 year
All sexes
Interventional
Not applicable
Khlong Luang, Changwat Pathum Thani, 12120, Thailand
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participant will apply silicone dressing at 2 weeks after TKA on one side of knee.
Silicone dressing will change every week until 12 week postoperative.
Time frame: 6week, 3month, 6month, 1 year
Vancouver Scar Scale evaluate by dermatologist (point) Range from 0-13 (0 mean best, 13 mean worst)
Time frame: 6week, 3month, 6month, 1 year
evaluate by long arm goniometer (degree)
Time frame: 6week, 3month, 6month, 1year
Forgotten joint score (point) (range 0-100, 0 mean worst, 100 mean best)
Time frame: 6week, 3month, 6month, 1year
modified WOMAC score (point) (range 0-96, 0 mean best, 96 mean worst)
Time frame: 6week, 3month, 6month, 1year
evaluate by visual analog scale (point) (0-10, 0 mean best, 10 mean worst)
Time frame: 6week, 3month, 6month, 1year
evaluate by visual analog scale (point) (0-10, 0 mean best, 10 mean worst)
Time frame: 6week, 3month, 6month, 1year
Wound complication ex deep joint infection, surgical site infection, wound dehiscence
Thammasat University Hospital
Other
Efficacy of a Soft Silicone Dressing to Prevent Scarring After Bilateral Total Knee Arthroplasty: A Randomized Paired Controlled Trial.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04707131
Cicatrix, Fibrosis
Cheongju-si, South Korea
View Trial DetailsNCT01038297
Cicatrix, Fibrosis
Chicago, Illinois, United States
View Trial DetailsNCT01037413
Cicatrix, Fibrosis
La Jolla, California, United States
View Trial DetailsNCT01037985
Cicatrix, Fibrosis
La Jolla, California, United States
View Trial Details